课题基金 / 基金详情

Pathogenesis of Glaucomatous Optic Nerve Damage

Pathogenesis of Glaucomatous Optic Nerve Damage
青光眼视神经损伤的发病机制
批准号:
7525618
负责人:
Harry Alan Quigley
金额:
$58.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-08-01 至 2011-07-31
关键词:
1 year old1-Phosphatidylinositol 3-Kinase3-DimensionalAccountingAcepromazineActive SitesAcuteAdoptedAdultAdverse effectsAffectAfricanAgeAge-MonthsAirAlgorithmsAmacrine CellsAmilorideAmyloid beta-Protein PrecursorAnatomyAnesthesia proceduresAnimalsAnisotropyAnnexinsAnteriorAntibodiesAortaApoptosisApoptoticAppearanceAreaAstrocytesAtlasesAttenuatedAutoantibodiesAwardAxonAxonal TransportBackBehaviorBiochemicalBiological AssayBiological PreservationBiomechanicsBirthBlood PressureBlood VesselsBlood capillariesBlood flowBody TemperatureBrainBrain-Derived Neurotrophic FactorBreedingBuffersBurr hole procedureCCAAT-Enhancer-Binding ProteinsCaliberCalibrationCandidate Disease GeneCannulasCannulationsCattleCell CountCell DeathCell NucleusCell SurvivalCell TherapyCell physiologyCellsCellular MorphologyCellular StructuresCeruloplasminCessation of lifeCharacteristicsChemicalsChoroidChronicCiliary BodyCiliary Neurotrophic FactorClassificationClinicalCodeCollagenCollagen FibrilCollagen GeneCollagen Type ICompanionsComplementary DNAComplexComputer softwareConfocal MicroscopyConnective TissueConnective Tissue AlterationCopaxoneCorneaCrush InjuryCryopreservationCryoultramicrotomyCytolysisCytoprotectionDataData CollectionDefectDendritesDeteriorationDevelopmentDevicesDiastolic blood pressureDigoxigeninDimensionsDistalDoctor of PhilosophyDoseDropsDyesDynein ATPaseEconomic InflationEdetic AcidEhlers-Danlos SyndromeElastinElastin FiberElementsEndothelinEndothelin ReceptorEngineeringEnglandEuropeanEvaluationEventExcisionExfoliation SyndromeExhibitsExposure toExpressed Sequence TagsEyeEye BanksFBN1FOS geneFailureFamily suidaeFeedbackFerritinFiberFibrillar CollagenFibroblastsFilmFluorescenceFluorochromeFreezingFrozen SectionsFundingGanglion Cell LayerGene ActivationGene ClusterGene ExpressionGene MutationGenesGlassGlaucomaGluesGlyceraldehydeGrantGraphGray unit of radiation doseGrowthGrowth FactorHandHeadHeat shock proteinsHeightHigh PrevalenceHistocytochemistryHomozygoteHourHumanHuman bodyHydration statusHydrophthalmosImageImage AnalysisImmediate-Early GenesImmunoblottingImmunofluorescence ImmunologicImmunohistochemistryIn SituIn Situ HybridizationIn VitroInbred StrainIncidenceIndia ink stainIndiumIndividualInduced MutationInfantInferiorInflammationInflammatoryInjection of therapeutic agentInjuryInner Nuclear LayerInvestigationInvestmentsJUN geneJawKeratoconusKetamineKnock-outKnockout MiceLabelLaboratoriesLasersLateral Geniculate BodyLeadLeftLengthLeucineLifeLightLinkLiquid substanceLocationLong-Term EffectsLosartanMAPK10 geneMAPK14 geneMAPK8 geneMaintenanceManuscriptsMapsMarfan SyndromeMasksMatrix MetalloproteinasesMeasurableMeasurementMeasuresMechanicsMediatingMediator of activation proteinMedical TechnologyMembraneMeridiansMessenger RNAMethodologyMethodsMicroscopeMicroscopicMicrospheresMitogen-Activated Protein KinasesModelingMolecularMolecular StructureMonitorMonkeysMorphologyMotorMouse ProteinMouse StrainsMovementMultivariate AnalysisMusMuscleMutant Strains MiceMutateMutationMydriasisMyopiaNamesNatural regenerationNeedlesNerveNerve CrushNerve DegenerationNerve FibersNerve Growth Factor ReceptorsNerve TissueNeuritesNeurofilament-HNeurogliaNeuronsNeurosciences ResearchNeurotransmittersNormal salineNuclearObstructionOcular HypertensionOpen-Angle GlaucomaOperative Surgical ProceduresOphthalmoscopyOptic DiskOptic NerveOptic Nerve InjuriesOptic Nerve TransectionsOpticsOrganellesOryctolagus cuniculusOsmiumOutcomeOutcome MeasureOutcome StudyPaperPartner in relationshipPathogenesisPathway interactionsPatternPeer ReviewPerfusionPeripheralPermeabilityPeroxidasesPersonsPharmaceutical PreparationsPhasePhenotypePhenylephrinePhosphorylationPhysiologic Intraocular PressurePhysiologicalPhysiologyPolyethylenesPolystyrenesPositioning AttributePredispositionPresynaptic TerminalsPrevalencePreventivePrimatesProcessProductionProgress ReportsPropertyProtease InhibitorProtein DephosphorylationProtein Kinase CProtein-Lysine 6-OxidaseProteinsProtocols documentationPublicationsPublishingPumpPyroxylinRNARadialRadioactiveRampRattusReactionReadingRecoveryRelative (related person)RelaxationReportingResearchResearch DesignResearch PersonnelResolutionRetinaRetinalRetinal Ganglion CellsReverse TranscriptionRiboflavinRibonucleasesRiluzoleRiskRisk FactorsRodentRoleSagittariaSalineSample SizeSamplingScaffolding ProteinScintillation CounterScintillation CountingScleraSecureSedation procedureSerumSideSignal PathwaySignal TransductionSimulateSiteSkinSlideSodium Dodecyl Sulfate-PAGESolutionsSourceSpecific qualifier valueSpecimenSpottingsStagingStaining methodStainsStem cellsStressStress TestsStretchingStructureSubgroupSucroseSuggestionSupravalvular aortic stenosisSurfaceSurgical incisionsSyringesTNF geneTRAAK channelTailTechniquesTechnologyTemperatureTendon structureTestingTheoretical modelTherapeuticThickThree-dimensional analysisThromboplastinThrombospondin 1TimeTissue ModelTissue SampleTissuesTo specifyTolonium chlorideToxic effectTransducersTransferrinTransforming Growth Factor betaTransgenic MiceTransgenic OrganismsTranslatingTranslationsTransmission Electron MicroscopyTravelTreesTrephine holeTropicamideTropoelastinTumor Necrosis Factor-alphaTumor Necrosis FactorsTupaiidaeUltraviolet RaysUp-RegulationVaccinationVariantVial deviceVisual FieldsVisual PathwaysWallerian DegenerationWestern BlottingWood materialWorkXylazineactive controladeno-associated viral vectoraerobic respiration control proteinaggrecananterior chamberanterograde transportbasebiglycanbonecDNA ArrayscDNA Librarycalbindincalbindin-D28Kcapillarycell injurycellular engineeringcentral retinal arterycomparativecomputerized data processingcongenicconnective tissue developmentcrosslinkcyclin D2cytokinedensitydesigndigitaldigital imagingdynactinexperiencefibrillinfibromodulinfluorescence microscopeganglion cellgene therapyhigh intraocular pressurehorizontal cellhuman diseaseimaging modalityimprovedin vivoinhibitor/antagonistinjuredinstrumentinterestkillingslaser capture microdissectionlectureslenslumicanmRNA Expressionmature animalmicrosystemsmorphometrymouse modelmutantmyocilinneonatal humannestin proteinneurofilamentneuroinflammationneuronal cell bodyneurotrophic factorneutralizing antibodynoveloverexpressionparaformparticlepressurepreventprimary outcomeprogramspromoterprotective effectrat genomeregional differencerelating to nervous systemresearch studyresponseresponse to injuryrestorationretinal damageretinal neuronretrograde transportsecondary outcomestress-activated protein kinase 1successsuperior colliculus Corpora quadrigeminasyntaxintraittranscription factortransmission processtwo-dimensionalvalidation studies

项目摘要

项目成果

Harry Alan Quigley的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To reduce the project to a 2 year proposal, I have retained the overall theme which is to study the effect of connective tissues of the sclera and peripapillary nerve head on axonal injury and RGC death. The portions of the 5 year proposal that were eliminated were much of former Aim 2 and 3 which dealt with studies of nerve head capillary function, and the roles of endothelin and tumor necrosis factor _ in RGC injury. We expect to test the role of connective tissue alteration in the ultimate survival of RGC in chronic experimental glaucoma (former Aim 4, now Aim 3), including the effect of chemical scleral cross-linking. To complete the project in 2 years, we eliminated from the 5 year proposal Hypotheses 7, 8, 9, and 11.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Glaucomatous Optic Nerve Damage
  • 批准号:
    7646697
  • 项目类别:
  • 资助金额:
    $36.91万
  • 财政年份:
    2008
  • 负责人:
    Harry Alan Quigley
  • 依托单位:
CORE--TRANSMISSION & IMAGING EM
  • 批准号:
    6993157
  • 项目类别:
  • 资助金额:
    $12.32万
  • 财政年份:
    2004
  • 负责人:
    Harry Alan Quigley
  • 依托单位:
The Wilmer Institute Mentored Clinician Scientist Scholar Program-Supplement
  • 批准号:
    10405937
  • 项目类别:
  • 资助金额:
    $8.64万
  • 财政年份:
    2003
  • 负责人:
    Harry Alan Quigley
  • 依托单位:
The Wilmer Institute Mentored Clinical-Scientist Scholar Program
  • 批准号:
    8088099
  • 项目类别:
  • 资助金额:
    $35.31万
  • 财政年份:
    2003
  • 负责人:
    Harry Alan Quigley
  • 依托单位: